|
| 1-[(3,4-dichlorophenyl)methyl]-N-[4-(hydroxymethyl)phenyl]-5-methyl-1H-1,2,3-triazole-4-carboxamide Basic information |
Product Name: | 1-[(3,4-dichlorophenyl)methyl]-N-[4-(hydroxymethyl)phenyl]-5-methyl-1H-1,2,3-triazole-4-carboxamide | Synonyms: | 1-[(3,4-dichlorophenyl)methyl]-N-[4-(hydroxymethyl)phenyl]-5-methyl-1H-1,2,3-triazole-4-carboxamide;SCD inhibitor 1;SCD inhibitor 1 GS1940029;1H-1,2,3-Triazole-4-carboxamide, 1-[(3,4-dichlorophenyl)methyl]-N-[4-(hydroxymethyl)phenyl]-5-methyl-;SCD inhibitor GSK1940029;Alzheimer's,cancer,SCD inhibitor-1,cardiovascular,diabetes,inhibit,obesity,SCD inhibitor1,metabolic,GSK 1940029,elevated,GSK-1940029,Stearoyl-CoA Desaturase (SCD),GSK1940029,Inhibitor,syndrome,SCD,enzyme | CAS: | 1150701-66-8 | MF: | C18H16Cl2N4O2 | MW: | 391.25 | EINECS: | | Product Categories: | | Mol File: | 1150701-66-8.mol | |
| 1-[(3,4-dichlorophenyl)methyl]-N-[4-(hydroxymethyl)phenyl]-5-methyl-1H-1,2,3-triazole-4-carboxamide Chemical Properties |
storage temp. | Store at -20°C | solubility | DMSO : ≥ 32 mg/mL (81.79 mM) | form | Solid | color | Light yellow to yellow |
| 1-[(3,4-dichlorophenyl)methyl]-N-[4-(hydroxymethyl)phenyl]-5-methyl-1H-1,2,3-triazole-4-carboxamide Usage And Synthesis |
Description | GSK1940029, also known as SCD Inhibitor 1, is a SCD Inhibitor. GSK1940029 is a potential topical treatment of acne, |
| 1-[(3,4-dichlorophenyl)methyl]-N-[4-(hydroxymethyl)phenyl]-5-methyl-1H-1,2,3-triazole-4-carboxamide Preparation Products And Raw materials |
|